MOMA was established in 2008 at the Science Center Skejby, nearby the hospital. From March 2018 MOMA was part of and managed by the Department of Clinical Biochemistry at Aarhus University Hospital.
From January, 1st 2020 MOMA emerged as independent hospital department again, having its own management from February, 1st 2020.
MOMA houses the National Whole Genome Sequencing Center West under the Danish National Genome Center, which will contribute to the development of precision medicine to the benefit of patients by sequencing 60.000 genomes from 2019 to approximately 2023.
Read more about the department at moma.auh.dk (Danish) or at https://www.en.auh.dk/departments/department-of-molecular-medicine-moma/ (English).
Our main activities
Molecular clinical research, mainly in cancer
National WGS CenterWest under the Danish National Genome Center
MOMA is accredited by DANAK/ILAC by the international laboratory standard DS/EN ISO 15189:2013 for medical examination - genetics since 2012.
Our comitted staff is counting more than 100 members, including six professors, consultants, doctors, molecular biologists, researchers, bioinformaticians, medical technologists and students.
MOMA collaborates with leading laboratories worldwide, especially in clinical translational studies.
MOMA houses a wide range of state-of-the-art laboratory equipment.
We receive substantial research fundings from more than 50 funds including The Danish Cancer Society, The Innovation Fund Denmark , The Lundbeck Foundation, The Independent Research Fund Danmark, Novo Nordisk Foundation, Neye Foundation and many others.
|NGS Core Center||